Table 1.
Participant demographics.
| Screened | High-risk (tested) | High-risk (refused) | 95% CI | P value | |
|---|---|---|---|---|---|
| N | 999 | 144 | 103 | ||
| Age: mean (SD) | 53.8 (19.6) | 53.5 (18.0) | 55.8 (19.1) | −2.4, 7.0 | 0.34 |
| Male sex: N (%) | 464 (46.4) | 77 (59.7) | 52 (50.5) | −3.3, 21.4 | 0.15 |
| Country | |||||
| Canada | 607 (60.8) | 66 (45.8) | 33 (32.0) | 1.4, 25.4 | 0.03 |
| Endemic | 136 (13.6) | 63 (43.8) | 60 (58.3) | 1.9, 26.5 | 0.02 |
| Nonendemic | 256 (25.6) | 15 (10.4) | 10 (9.7) | −7.6, 8.2 | 0.86 |
| IVDU | |||||
| Ever used | 40 (4.0) | 26 (18.0) | 5 (4.9) | 5.0, 20.7 | 0.002 |
| Current use | 11 (1.1) | 5 (3.5) | 1 (0.97) | −2.2, 7 | 0.20 |
| Past use | 29 (2.9) | 21 (14.6) | 4 (3.9) | 3.2, 17.8 | 0.006 |
| Blood transfusion | 48 (19.4) | 28 (19.4) | 13 (12.6) | −2.8, 15.6 | 0.16 |
| Incarceration | 73 (7.3%) | 41 (28.5) | 22 (21.4) | −4.0, 17.5 | 0.21 |